Ep127: Jeb Keiper on Computational Drug Discovery

The Long Run with Luke Timmerman - A podcast by Timmerman Report

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.

Visit the podcast's native language site